Femoston 1/10 & 2/10/Femoston Conti 1/5

Femoston 1/10 & 2/10/Femoston Conti 1/5 Dosage/Direction for Use

estradiol + dydrogesterone

estradiol

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Full Prescribing Info
Dosage/Direction for Use
Method of administration: For oral use.
Femoston can be taken irrespective of food intake.
Paediatric population: There is no relevant indication for the use of Femoston in the paediatric population.
Femoston 1/10: One tablet, containing 1 mg estradiol, daily during 14 consecutive days per cycle of 28th days on one tablet, containing 1 mg estradiol and 10 mg dydrogesterone, daily during the remaining 14 days has to be taken immediately after a 28 day cycle, the next treatment cycle is to be started. Patients should take one tablet a day orally, according to the sequence indicated on the package. Medication is to be continued without interruption.
If the patient is still menstruating, it is recommended to begin treatment on the first day after onset of menstruation.
If the patient is menstruating infrequently it is advisable to begin treatment after 10-14 days monotherapy of progestogen ("chemical curettage").
In patients who had their last period more than approximately 12 months ago treatment can be started at any time.
Femoston 2/10 and Femoston conti 1/5: Should be taken continuously without a break between packs.
For initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration (see also Precautions) should be used.
Depending on the clinical response, the dosage can be subsequently be adjusted.
Patients changing from another continuous sequential or cyclical preparation should complete the 28-day cycle and then change to Femoston 2/10 or Femoston conti 1/5.
Patients changing from a continuous combined preparation may start therapy at any time.
If a dose has been forgotten, it should be taken as soon as possible. If more than 12 hours have elapsed, treatment should be continued with the next tablet without taking the forgotten tablet. The likelihood of breakthrough bleeding or spotting may be increased.
Femoston 2/10: The oestrogen is dosed continuously. The progestogen is added for the last 14 days of every 28 day cycle, in a sequential manner.
Treatment commences with one brick red tablet daily for the first 14 days followed by one yellow tablet daily for the next 14 days, as directed on the 28 day calendar pack.
In general, sequential combined treatment should start with Femoston 1/10.
Femoston conti 1/5: The oestrogen and the progestogen are to be taken every day without interruption. One tablet is to be taken daily for a 28 day cycle.
Continuous combined treatment may be started with Femoston 1/5 depending on the time since menopause and the severity of the symptoms.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in